PTC Therapeutics, Inc. (PTCT) is a publicly traded Healthcare sector company. As of May 21, 2026, PTCT trades at $68.61 with a market cap of $5.82B and a P/E ratio of -28.67. PTCT moved +0.78% today. Year to date, PTCT is -7.48%; over the trailing twelve months it is +50.47%. Its 52-week range spans $34.57 to $87.50. Analyst consensus is strong buy with an average price target of $93.10. Rallies surfaces PTCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PTC Therapeutics, Inc. (PTCT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. PTCT moved +0.78% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $68.61 |
| Market Cap | $5.82B |
| P/E Ratio | -28.67 |
| EPS | $-2.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $87.50 |
| 52-Week Low | $34.57 |
| Volume | 920.92K |
| Avg Volume | 0 |
| Revenue (TTM) | $827.11M |
| Net Income | $-186.73M |
| Gross Margin | 0.00% |
13 analysts cover PTCT: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $93.10.